Study from JAMA reveals that users of GLP-1 agonists, recent drugs for weight management, show a heightened risk of gastrointestinal complications like intestinal obstruction, gastroparesis, and pancreatitis. Though these effects are rare, those considering these drugs for weight loss should weigh the benefits against potential risks, especially if not using them for diabetes.
Vibe Check: FDA Set to Decide Future of MDMA-Assisted Therapy This Week – Psychedelic Alpha
In her 2023 book, I Feel Love, journalist Rachel Nuwer charts the history of how MDMA ‘emerged from the shadows to the forefront of a
August 6, 2024